Glenmark Life Sciences Limited
NSE:GLS.NS
1096.1 (INR) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||
| Net Income
| 6,312.9 | 6,286.09 | 5,649.25 | 4,709.44 | 4,210.67 | 2,282.97 | -4.34 |
| Depreciation & Amortization
| 534.52 | 420.94 | 378.77 | 333.94 | 293.68 | 192.62 | 0 |
| Deferred Income Tax
| 0 | -1,483.03 | -1,297.36 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 43.75 | 31.85 | 34.98 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| -1,340.8 | -1,969.62 | 998.4 | -1,075.77 | -1,902.63 | -932.56 | -4.68 |
| Accounts Receivables
| 378.6 | -1,336.49 | -592.15 | 81.01 | -1,781.09 | -858.17 | -0.31 |
| Inventory
| -826.26 | -879.27 | -28.23 | -1,006.46 | -119.32 | 588.13 | 0.46 |
| Accounts Payables
| -341.21 | 981.77 | 737.49 | 340.89 | 193.02 | -590.17 | -4.83 |
| Other Working Capital
| -551.93 | -735.63 | 881.29 | -491.21 | -195.24 | -72.35 | 0 |
| Other Non Cash Items
| -104.75 | -152.19 | 211.81 | -86.48 | -651.65 | -1,439.51 | 8.89 |
| Operating Cash Flow
| 4,135.15 | 3,134.04 | 5,975.85 | 3,881.13 | 1,950.07 | 103.52 | -4.81 |
| Investing Activities: | |||||||
| Investments In Property Plant And Equipment
| -1,289.69 | -1,701.96 | -1,321.72 | -679.93 | -511.66 | -93.25 | 0 |
| Acquisitions Net
| 4.65 | 1.74 | 4.69 | 16.34 | 2.93 | 0 | 0 |
| Purchases Of Investments
| 0 | -1.74 | -4.69 | -28.05 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 1.11 | 28.05 | -16.34 | 0 | 0 | 0 |
| Other Investing Activites
| 124.86 | 159.4 | 71.39 | 20.64 | 3.55 | 4.11 | 0 |
| Investing Cash Flow
| -1,164.83 | -1,541.45 | -1,222.28 | -687.34 | -505.18 | -89.14 | 0 |
| Financing Activities: | |||||||
| Debt Repayment
| -22.09 | -16.43 | -9,605.59 | -2,137.81 | -1,365.52 | -9.65 | -4.86 |
| Common Stock Issued
| 0 | 0 | 10,118.54 | 0 | 0 | 15 | 0 |
| Common Stock Repurchased
| 0 | 0 | 9,605.59 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -2,756.86 | -3,859.18 | -1,286.54 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -15.46 | -0.32 | -9,619.96 | -2,137.81 | -1,365.52 | 5.35 | 4.86 |
| Financing Cash Flow
| -2,794.41 | -3,875.93 | -787.96 | -2,137.81 | -1,365.52 | 5.35 | 4.86 |
| Other Information: | |||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0.81 | 0 |
| Net Change In Cash
| 175.91 | -2,283.34 | 3,965.61 | 1,055.98 | 79.37 | 20.54 | 0.05 |
| Cash At End Of Period
| 3,014.14 | 2,838.23 | 5,121.57 | 1,155.96 | 99.98 | 20.61 | 0.07 |